Khiron Life Sciences to Present at Canaccord Genuity 2nd Annual Cannabis Conference

TORONTO, May 16, 2018 /CNW/ - Khiron Life Sciences Corp. (the "Company"), a Canadian integrated medical cannabis company with its core operations in Colombia, today announced that Alvaro Torres, President and Chief Executive Officer, will present at the Canaccord Genuity 2nd Annual Cannabis Conference in New York City. Details as follows:

Date: Thursday, May 17, 2018

Time: 10:20 AM Eastern Daylight Time

Location: The Westin Grand Central, New York

The presentation will be webcast live and can be accessed at:

http://wsw.com/webcast/canaccord31/kls/

The presentation will also be archived under the investors section of the Company website for 30 days. The Company website can be accessed at www.khiron.ca.

About Khiron Life Sciences Corp.

Khiron Life Sciences is a Canadian integrated medical cannabis company with its core operations in Colombia. Khiron combines leading international scientific expertise, agricultural advantages and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in Latin America. Khiron has received licences in Colombia for high- and low-tetrahydrocannabinol (THC) medical cannabis, and is now in receipt of all licences required for the cultivation, production, domestic distribution, and international export of both THC and cannabidiol (CBD) medical cannabis.

Further information on the company can be accessed through the following link: www.khiron.ca

SOURCE Khiron Life Sciences Corp.

For further information: Darren Collins, Chief Financial Officer, T: +1 (705) 527-3564, E: dcollins@khiron.ca; U.S. Investor Relations, Lisa Wilson, In-Site Communications, Inc., T: +1 (917) 543-9932, E: lwilson@insitecony.com; Canadian Investor Relations, Nicole Marchand, GRIT Capital, T: +1 (416) 428-3533, E: nmarchand@gritcapital.ca

Released May 16, 2018